Brigit Biofarmaka Teknologi Tbk. vs Aesler Grup Internasional Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Aesler Grup Internasional Tbk. trades at Rp1,560 (market cap 2.11T, 958.6K 24h volume). The key difference: Aesler Grup Internasional Tbk. is far larger — about 12.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Aesler Grup Internasional Tbk. is more actively traded (958.6K versus 592.2K). Which is the better fit depends on your goals.
| OBAT | RONY | |
|---|---|---|
Market Cap | 172.82B | 2.11T |
Volume | 592.2K | 958.6K |
Lot | 5.92K | 9.59K |
Turnover | 147.05M | 1.69B |
Average Price | 248.31 | 1,768.02 |
Value | 147.05M | 1.69B |
Indicative Equilibrium Price | 254 | 1,560 |
Indicative Equilibrium Volume | 10 | 61 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Aesler Grup Internasional Tbk (the Company) was established in Republic of Indonesia based on the Notarial Deed No. 14 dated August 4, 2017 of Ferdinandus Indra Santoso Atmajaya, S.H., M.Kn., Notary in Jakarta. The Company started its commercial activity in 2017.
Read more on RONY →